Outlook Therapeutics (OTLK) said its compensation committee granted 1 million options to purchase common stock to Chief Executive C Russell Trenary III....
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Outlook Therapeutics (OTLK) said Friday the US Food and Drug Administration has accepted the drugmaker's biologics license application for ONS-5010m=, an...
Kurt J Hilzinger, Director, on October 04, 2022, executed a purchase for 111,203 shares in Outlook Therapeutics (OTLK) for $142,512. Following the Form 4...
Outlook Therapeutics (OTLK) has partnered with AmerisourceBergen (ABC) to prepare for the potential commercial launch of ONS-5010/Lytenava in the US, if...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Outlook Therapeutics (OTLK) said Tuesday it has re-submitted its biologics license application to the Food and Drug Administration for ONS-5010, an...
Health care stocks continued to sputter this afternoon, with the NYSE Health Care Index sinking 0.8% and the SPDR Health Care Select Sector ETF (XLV) down...
Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 2.2% and the SPDR Health Care Select Sector ETF (XLV) down...
Outlook Therapeutics (OTLK) said Tuesday that it made a full cash pre-payment of its unsecured convertible promissory note dated Nov. 4, 2020, and that all...